🎉 Hey Gate Square friends! Non-stop perks and endless excitement—our hottest posting reward events are ongoing now! The more you post, the more you win. Don’t miss your exclusive goodies! 🚀
1️⃣ #TokenOfLove# | Festival Ticket Giveaway
Cheer for your idol on Gate Square! Pick your favorite star — HyunA, SUECO, DJ KAKA, or CLICK#15 — and post with SingerName + TokenOfLove hashtag to win one of 20 music festival tickets.
Details 👉 https://www.gate.com/post/status/13217654
2️⃣ #GateTravelSharingAmbassadors# | Share Your Journey, Win Rewards
Gate Travel is now live! Post with the hashtag and sha
Sanyuan Bio: Luxin Capital plans to reduce its stake in the company by no more than 3%.
Jin10 data reported on July 10th that Sanyuan Biotechnology announced that its shareholder, Luxin Capital, plans to reduce its holdings in the company by no more than 6 million shares via concentrated bidding and Block Trading within 3 months after 15 trading days from the date of the announcement, which does not exceed 3% of the total share capital after excluding the shares in the company's repurchase special securities account. The reason for the reduction is the company's operational development needs, and the reduction price will be determined based on market prices. Luxin Capital is not the company's controlling shareholder or actual controller, and this reduction will not lead to a change in the company's control or have a significant impact on the company's governance structure and sustainable operation.